Health
EBMT trial shows improvements in treatment of Severe Aplastic Anaemia – EurekAlert
The European Society for Blood and Marrow Transplantation (EBMT), Europe’s collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs…
The European Society for Blood and Marrow Transplantation (EBMT), Europe’s collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs virtual 46th Annual Meeting. Preliminary data show that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with Severe Aplastic Anaemia (SAA).
SAA is a condition in which the bone m…
-
Noosa News20 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
General22 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News18 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General22 hours agoDisloyal far-left breakaways are coming for Labor